HFS
IMVT icon

Hughes Financial Services’s Immunovant IMVT Stock Holding History

Hughes Financial Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77 Buy
2
+1
+100% +$30 ﹤0.01% 1505
2026
Q1 		$25 Buy
+1
New +$26 ﹤0.01% 1577

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hughes Financial Services's IMVT Position: Q2 2026 in Review

Hughes Financial Services increased its Immunovant (IMVT) stake by 100% in Q2 2026, buying an estimated $30 and bringing the position to 2 shares worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Hughes Financial Services first reported a position in IMVT in Q1 2026 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Hughes Financial Services held 2 shares of Immunovant worth $77 as of Q2 2026.
  • Hughes Financial Services bought 1 Immunovant share in Q2 2026, an estimated $30.
  • Immunovant made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1505 holding.
  • Hughes Financial Services first reported a position in Immunovant in Q1 2026 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.